Sorin Group Executes Agreement to Acquire Endoscopic Vessel Harvesting Business from Datascope, Inc

  
    
  
  
    
      Sorin Group (MIL:SRN) (Reuters code: SORN.MI) announced today that it 
      has entered into a binding Asset Purchase Agreement for the purchase of 
      the Clearglide(R) endoscopic vessel harvesting product line from 
      Datascope Inc. (NASDAQ:DSCP). Further terms of the transaction were not 
      disclosed. The transaction is contingent on the closing of the 
      acquisition of Datascope by Getinge AB, satisfaction of typical 
      contractual conditions, and satisfaction of anti-trust procedures in the 
      United States.
    
    
      The vessel harvesting product line will, upon closing of the 
      transaction, be integrated into Sorin Group’s Cardiopulmonary Business 
      Unit.
    
    
      Endoscopic vessel harvesting (‘EVH’) devices enable less-invasive 
      techniques for the harvesting of suitable vessels for use in conjunction 
      with coronary artery bypass grafting. EVH procedures replace traditional 
      open vessel harvesting and avoid significant pain and discomfort for 
      patients during the recovery period.
    
    
      About the Sorin Group
    
    
      The Sorin Group (www.sorin.com), 
      a world leader in the development of medical technologies for cardiac 
      surgery, offers innovative therapies for cardiac rhythm dysfunctions, 
      interventional cardiology, and the treatment of chronic kidney diseases. 
      At the Sorin Group, more than 4,000 employees work to serve over 5,000 
      public and private treatment centers. Every year, over 1 million 
      patients are treated with the devices of Sorin Group in more than 80 
      countries. For more information, please visit: www.sorin.com